Benzaclin (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Benzaclin drug offered from Valeant Pharmaceuticals North America LLC. This Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
| NON-PROPRIETARY NAME: | Clindamycin phosphate and benzoyl peroxide |
| SUBSTANCE NAME: | CLINDAMYCIN PHOSPHATE; BENZOYL PEROXIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2000-12-21 |
| END MARKETING DATE: | 0000-00-00 |
Benzaclin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Benzaclin from Valeant Pharmaceuticals North America LLC |
| LABELER NAME: | Valeant Pharmaceuticals North America LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 50(mg/g; mg/g) |
| START MARKETING DATE: | 2000-12-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-5190_01abb87e-1d4e-4f45-bf8c-76b9f9c3227d |
| PRODUCT NDC: | 0187-5190 |
| APPLICATION NUMBER: | NDA050756 |
Other CLINDAMYCIN PHOSPHATE; BENZOYL PEROXIDE Pharmaceutical Manufacturers / Labelers:
